STAT3 and cancer: IL-6 forms a complex with IL-6 receptor (IL-6R) and gp130, which mediates cancer cell development through the SHP2-ERK-MAPK and STAT3-BCL-2 pathways (Mihara et al., 2012; Heo, Wahler and Suh 2016).